NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

por Schultz-Thater, E, Noppen, C, Gudat, F, Dürmüller, U, Zajac, P, Kocher, T, Heberer, M, Spagnoli, G C
Publicado 2000

Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes

por Feder-Mengus, C, Ghosh, S, Weber, W P, Wyler, S, Zajac, P, Terracciano, L, Oertli, D, Heberer, M, Martin, I, Spagnoli, G C, Reschner, A
Publicado 2007

Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes

por Adamina, M, Bolli, M, Albo, F, Cavazza, A, Zajac, P, Padovan, E, Schumacher, R, Reschner, A, Feder, C, Marti, W R, Oertli, D, Heberer, M, Spagnoli, G C
Publicado 2004

PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation

por Gianni-Barrera, R., Butschkau, A., Uccelli, A., Certelli, A., Valente, P., Bartolomeo, M., Groppa, E., Burger, M. G., Hlushchuk, R., Heberer, M., Schaefer, D. J., Gürke, L., Djonov, V., Vollmar, B., Banfi, A.
Publicado 2018